Fingerprint
Dive into the research topics of 'Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically